Gianluca Trifirò
Department of Diagnostics and Public Health, University of Verona
Italy
Editor-in-Chief

Promover la seguridad de los pacientes y la transparencia en los procesos regulatorios mediante la publicación global en acceso abierto de evidencia científica rigurosa en el ámbito de la regulación farmacéutica.
About the journal
Start your submission and get more impact for your research by publishing with us.

Ready to publish? Check our author guidelines for everything you need to know about submitting, from choosing a journal and section to preparing your manuscript.

Reviewing a manuscript? See our editor guidelines for everything you need to know about the Frontiers peer review process.

Our rigorous and transparent peer review combines expert assessment with constructive dialogue to strengthen your manuscript.

Article processing charges apply to articles accepted for publication by our external editors after rigorous peer review.
Department of Diagnostics and Public Health, University of Verona
Italy
Editor-in-Chief
University of Florence
Italy
Specialty Chief Editor
Substance-Based Medical Devices
University of Bern
Switzerland
Specialty Chief Editor
Maternal-Fetal Medicine
Netherlands Pharmacovigilance Centre Lareb
Netherlands
Specialty Chief Editor
Vaccine Safety and Regulation
University of Milano-Bicocca
Italy
Specialty Chief Editor
Pharmaceutical Policy and Regulation
University of Pisa
Italy
Specialty Chief Editor
Clinical Drug Safety
Harvard Medical School and Harvard Pilgrim Health Care Institute
United States
Specialty Chief Editor
Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
University of Salerno
Italy
Associate Editor
Substance-Based Medical Devices
99 editors · 0 reviewers
Original Research
Published
Rominder Singh · Mukesh Pareek · Michael Prokle · Eduardo Sanchez · Uwe Hohgrawe · Jared R. Auclair
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2026.1718379
Original Research
Published
Elena-Mirabela Velişcu · Cecilia Cagnotta · Maria Giuseppa Sullo · Antonietta Anatriello · Francesco Salvo · Cristina Scavone
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1736759
Original Research
Published
Emeline Maisonneuve · Nicoletta Luxi · Chiara Bellitto · Francesco Ciccimarra · Monika Raethke · Florence van Hunsel · Thomas Lieber · Erik Mulder · Fabio Riefolo · Felipe Villalobos · Nicolas H. Thurin · Francisco Batel-Marques · Kathryn Morton · Fergal O'Shaughnessy · Brian Cleary · Simona Sonderlichová · Andreea Farcas · Camelia Bucsa · Guillaume Favre · Satu J. Siiskonen · David Baud · Miriam C. J. M. Sturkenboom · Gianluca Trifirò · Alice Panchaud
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1689349
Mini Review
Published
Camille V. Cook
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1599217
Review
Published
Irene Cristini · Elisabetta Poluzzi · Federica Soardo · Salvatore Crisafulli · Stefano Polesello · Ursula Kirchmayer · Marco Milani · Francesca Russo · Michele Nicoletti · Giovanna Scroccaro · Paola Deambrosis · Shima Tavakolian Haghighi · Jacopo Grisotto · Ugo Moretti · Giovanna Paolone · Gianluca Trifirò
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1681648
Review
Published
Giuseppe Alvaro · Michael Müller · Richa Chhibber · Robert Fuentes
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1698515
Original Research
Published
Baiqing Huang · Yirou Ma · Wenli Wang · Shaorui Gu · Xisheng Wang
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1721656
Policy and Practice Reviews
Published
Sonja Gandhi-Banga · Laurence Serradell · Deborah Layton · Jill Dreyfus · Nicolas Praet · Diana C. Garofalo · Vincent Bauchau · Scott P. Kelly · Lin Li
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2025.1651090
Open for submissions
Open for submissions
Open for submissions
El alcance incluye estudios de farmacovigilancia, análisis de datos de reacciones adversas, legislación y regulación de productos biológicos y biosimilares, errores de medicación, farmacoeconomía orientada a la seguridad y políticas de aprobación acelerada o condicional de fármacos.
Promover la seguridad de los pacientes y la transparencia en los procesos regulatorios mediante la publicación global en acceso abierto de evidencia científica rigurosa en el ámbito de la regulación farmacéutica.
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/advanced-methods-in-pharmacovigilance-and-pharmacoepidemiology
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/clinical-drug-safety
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/maternal-fetal-medicine
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/pharmaceutical-policy-and-regulation
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/substance-based-medical-devices
Official section page: https://www.frontiersin.org/journals/drug-safety-and-regulation/sections/vaccine-safety-and-regulation
Fees are charged only after acceptance. Waivers and discounts are available for authors with limited funding.
Fees and waivers policyInternal metrics, calculated on this platform and maintained by the editorial office.
Source: official publisher page · retrieved 2026-10-16
Some values were updated by the editorial office on 2026-10-21.